Does the execution of the release agreement by a Learningrx franchisee constitute an admission of liability by any party?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
It is understood and agreed that the settlement evidenced by this Release is a compromise of all claims herein specified, whether past, present or future, that such claims are doubtful and disputed, and that execution of this Release is not to be construed as an admission of liability on the part of any party.
Rather, liability is expressly denied.
The consideration expressly mentioned herein is the only consideration paid or to be paid by said parties hereby released.
No representations as to damages or liability have been made.
Source: Item 22 — CONTRACTS (FDD page 54)
What This Means (2025 FDD)
According to Learningrx's 2025 Franchise Disclosure Document, the execution of the release agreement does not constitute an admission of liability by any party. The document explicitly states that the settlement is a compromise of doubtful and disputed claims, and liability is expressly denied. This means that by signing the release, the franchisee is not admitting any fault or responsibility for any claims.
The release agreement aims to resolve any past, present, or future claims between the franchisee and Learningrx. It specifies that no representations regarding damages or liability have been made, and the consideration mentioned in the agreement is the only consideration paid. This protects both the franchisee and Learningrx from future claims related to the released matters.
This type of clause is common in franchise agreements to ensure that settlements are not interpreted as admissions of guilt or fault. It allows both parties to resolve disputes without the risk of setting a legal precedent. Franchisees should carefully review the release agreement with legal counsel to fully understand its implications and ensure they are comfortable with the terms before signing.